Astera Labs (NASDAQ:ALAB) Releases Q4 2025 Earnings Guidance

Astera Labs (NASDAQ:ALAB) issued an update on its fourth quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.50-0.510 for the period, compared to the consensus earnings per share estimate of 0.340. The company issued revenue guidance of -, compared to the consensus revenue estimate of $216.8 million.

Astera Labs Stock Up 0.2%

ALAB traded up $0.31 on Wednesday, hitting $179.62. The company had a trading volume of 5,216,364 shares, compared to its average volume of 5,236,680. The company has a market cap of $29.86 billion, a PE ratio of 320.75, a PEG ratio of 4.70 and a beta of 1.37. The business’s fifty day simple moving average is $196.79 and its 200 day simple moving average is $138.70. Astera Labs has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. The business had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business’s revenue for the quarter was up 103.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, analysts anticipate that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Analyst Ratings Changes

ALAB has been the subject of a number of recent analyst reports. Northland Capmk cut Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 22nd. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price target for the company. in a report on Tuesday, July 22nd. JPMorgan Chase & Co. boosted their price target on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a research note on Tuesday, September 2nd. Finally, Susquehanna boosted their target price on shares of Astera Labs from $80.00 to $125.00 and gave the stock a “neutral” rating in a research note on Thursday, August 7th. Thirteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $173.65.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the transaction, the director directly owned 385,863 shares of the company’s stock, valued at $66,858,482.01. This represents a 32.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Stefan A. Dyckerhoff sold 25,000 shares of the firm’s stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $173.42, for a total transaction of $4,335,500.00. Following the completion of the transaction, the director owned 99,154 shares in the company, valued at approximately $17,195,286.68. The trade was a 20.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 1,092,997 shares of company stock worth $192,231,120. 12.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. AQR Capital Management LLC lifted its position in Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares in the last quarter. Eventide Asset Management LLC acquired a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $626,000. Thrivent Financial for Lutherans acquired a new stake in Astera Labs during the 2nd quarter worth $592,000. Bayesian Capital Management LP acquired a new stake in shares of Astera Labs in the second quarter valued at approximately $571,000. Finally, Corient Private Wealth LLC acquired a new position in shares of Astera Labs during the 2nd quarter worth about $550,000. 60.47% of the stock is owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.